1,1'-Trimethylene bis(4-formylpyridinium bromide) dioxime (TMB-4) and 2-pyridine aldoxime methiodide (2-PAM) as adjuvants to atropine in the treatment of anticholinesterase poisoning.
D001285:Atropine; D001965:Bromides; D002800:Cholinesterase Inhibitors; D003521:Cyclopropanes; D006898:Hydroxylamines / Q000494:pharmacology*; D010710:Phosphates / Q000633:toxicity*; D011220:Pralidoxime Compounds; D011725:Pyridines / Q000494:pharmacology*; D014289:Trimedoxime
D001965:Bromides; D002800:Cholinesterase Inhibitors; D003521:Cyclopropanes; D006898:Hydroxylamines; D010710:Phosphates; D011220:Pralidoxime Compounds; D011725:Pyridines; D014289:Trimedoxime; D001285:Atropine; C030797:cyclopropane; C023666:pyridine; C028797:pralidoxime
CHOLINESTERASE/antagonists; HYDROXYLAMINES/pharmacology; PHOSPHATES/toxicology; PYRIDINES/pharmacology